Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumor, Adult 1

Interventions

Injections 54Cisplatin 48Paclitaxel 47Carboplatin 43Gemcitabine 38pembrolizumab 36Docetaxel 35Capecitabine 35Drug Therapy 34anlotinib 25Bevacizumab 25Cyclophosphamide 24icotinib 23Fluorouracil 23fludarabine 19Oxaliplatin 19Pemetrexed 17Leucovorin 16Irinotecan 15Temozolomide 14Nivolumab 14Doxorubicin 14Cetuximab 14camrelizumab 13apatinib 13Trastuzumab 12Rituximab 11Fulvestrant 11Etoposide 11tesetaxel 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × INDUSTRY × Catalytic Domain × Clear all
NCT06056323 2023-10-23

A Study of HB0045 Injection in Patients With Advanced Solid Tumors

Shanghai Huaota Biopharmaceutical Co., Ltd.

Phase 1/2 Unknown
71 enrolled
Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡